No Data
No Data
EU Pharma Majors Sanofi, Roche Trade Flat After Reiterated Guidance
Earnings Preview: REGN to Report Financial Results Pre-market on April 29
TD Cowen Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $800
Truist Financial Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $975
Wells Fargo Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $750
Express News | Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $975